Verastem Market Cap

Verastem has a market cap or net worth of $293.52 million as of May 17, 2024. Its market cap has increased by 239.73% in one year.

Market Cap

293.52M

Enterprise Value

238.11M

1-Year Change

239.73%

Ranking

#3313

Market Cap Chart

Since January 27, 2012, Verastem's market cap has increased from $213.30M to $293.52M, an increase of 37.61%. That is a compound annual growth rate of 2.63%.

Market Cap History

Date	Market Cap	% Change
May 15, 2024	332.30M	-0.30%
May 14, 2024	333.30M	9.49%
May 13, 2024	304.40M	1.43%
May 10, 2024	300.10M	-0.60%
May 9, 2024	301.90M	4.68%
May 8, 2024	288.40M	-0.17%
May 7, 2024	288.90M	-3.54%
May 6, 2024	299.50M	8.63%
May 3, 2024	275.70M	5.19%
May 2, 2024	262.10M	3.84%
May 1, 2024	252.40M	-
Apr 30, 2024	252.40M	3.61%
Apr 29, 2024	243.60M	2.65%
Apr 26, 2024	237.30M	1.80%
Apr 25, 2024	233.10M	-1.02%
Apr 24, 2024	235.50M	-3.13%
Apr 23, 2024	243.10M	-1.34%
Apr 22, 2024	246.40M	-1.00%
Apr 19, 2024	248.90M	-3.83%
Apr 18, 2024	258.80M	-5.62%
Apr 17, 2024	274.20M	-0.83%
Apr 16, 2024	276.50M	-1.25%
Apr 15, 2024	280.00M	-2.03%
Apr 12, 2024	285.80M	-4.32%
Apr 11, 2024	298.70M	4.51%

View and export this data all the way back to 2012. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AC Immune	339.26M
Tenaya Therapeutics	337.63M
Revance Therapeutics	336.20M
DocGo	334.66M
Sutro Biopharma	334.13M
Ventyx Biosciences	330.53M
Nektar Therapeutics	330.53M
Erasca	328.52M

Market Cap Rankings